Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct (BVS in STEMI)
Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct (BVS in STEMI)
Sponsor: Aarhus University Hospital Skejby
A PHASE3 clinical study on Acute ST Segment Elevation Myocardial Infarction, this trial is ongoing. The trial is conducted by Aarhus University Hospital Skejby and has accumulated 7 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Sep 2020 — Jan 2021 [monthly]
Unknown Status PHASE3
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Sep 2020 [monthly]
Active Not Recruiting PHASE3
▶ Show 2 earlier versions
-
Jul 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Jul 2017 [monthly]
Recruiting PHASE3
First recorded
Aug 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aarhus University Hospital Skejby
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Feiring
- Haukeland University Hospital
- Oslo University Hospital
- St. Olavs Hospital
- University Hospital of North Norway
For direct contact, visit the study record on ClinicalTrials.gov .